GlassScriptPhysician profile
Debashish Bose
NPI 1801940184
$13,623.55
in general payments reported to CMS, 2019-2025
34 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,951 · 2020: $140 · 2021: $2,655 · 2022: $472 · 2023: $1,570 · 2024: $4,589 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $2,181 · Travel and Lodging: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $2,181.28 |
| Travel and Lodging | $1,724.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,066.82 | 2019-2025 | Nanoknife, Smart Port Ct |
| Intuitive Surgical, INC. | $4,250.78 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $678.98 | 2020-2025 | Creon |
| Ethicon US, LLC | $607.18 | 2020-2025 | Enseal, Echelon Flex, Enseal X1 |
| Intera Oncology, INC | $322.04 | 2024 | Intera |
| Eisai INC. | $234.37 | 2023-2024 | |
| Medtronic, INC. | $164.72 | 2023 | Aquamantys(Tm), Signia |
| Davol INC. | $159.18 | 2019-2020 | |
| Acell, INC. | $121.35 | 2019 | |
| Olympus America INC. | $113.85 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $101.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $99.69 | 2022-2025 | Libtayo |
| Histosonics, INC. | $76.77 | 2024 | |
| Merck Sharp & Dohme LLC | $72.78 | 2020-2023 | Keytruda |
| Hologic Sales and Service, LLC | $59.29 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $51.94 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $36.12 | 2022-2023 | Opdivo |
| Biocompatibles, INC. | $35.33 | 2019 | |
| Integra Lifesciences Corporation | $33.76 | 2022 | |
| Nestle Healthcare Nutrition INC. | $28.96 | 2022 | |
| Kerecis Limited | $28.74 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.30 | 2023 | Arista Ah Flexitip |
| Springworks Therapeutics, INC. | $24.94 | 2024 | Ogsiveo |
| Novartis Pharmaceuticals Corporation | $24.24 | 2025 | |
| Caris Mpi, INC. | $23.34 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $22.96 | 2023 | Foundationone Cdx |
| Amgen INC. | $21.07 | 2023 | Vectibix, Nplate, Xgeva |
| Getinge USA Sales, LLC | $20.75 | 2025 | Maquet Powerled II |
| Seagen INC. | $18.68 | 2023 | Tivdak |
| Digestive Care, INC. | $18.01 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $17.31 | 2025 | |
| Olympus Corporation of The Americas | $16.95 | 2019 | |
| Covidien LP | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debashish Bose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.